Cognitive Behavioral Therapy for Alcoholism
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a special therapy called Female-Specific Cognitive Behavioral Therapy (FS-CBT) to determine its effectiveness for women veterans with Alcohol Use Disorder. The researchers aim to compare the effects of FS-CBT with the usual care provided by the VA. Women veterans enrolled in VA healthcare with a history of drinking beyond recommended limits might be suitable candidates for this trial. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance care for women veterans.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Female-Specific Cognitive Behavioral Therapy (FS-CBT) is a safe treatment for women with Alcohol Use Disorder. In earlier studies, women who tried FS-CBT experienced very few side effects. Most participants handled the therapy well, and researchers reported no major problems. This suggests that FS-CBT is a good option for women seeking help with alcohol use issues.12345
Why are researchers excited about this trial?
Researchers are excited about Female-Specific Cognitive Behavioral Therapy (FS-CBT) for alcoholism because it tailors the treatment to address unique challenges and experiences faced by women with alcohol use disorder. Unlike standard cognitive behavioral therapies, which are more generalized, FS-CBT incorporates gender-specific factors such as social roles, relationships, and biological differences, making it more personalized and potentially more effective for women. This targeted approach aims to improve engagement and outcomes by addressing the specific needs and triggers women may experience, which are often overlooked in traditional treatment programs.
What evidence suggests that this trial's treatments could be effective for alcohol use disorder?
Research has shown that Female-Specific Cognitive Behavioral Therapy (FS-CBT) can assist women with Alcohol Use Disorder (AUD). In this trial, one group of participants will receive FS-CBT alongside usual VA care. A study found that women who received FS-CBT reduced their alcohol use more effectively than those who received a more general therapy. This suggests that therapy tailored to the unique challenges women face can lead to better outcomes. FS-CBT also addresses issues specific to women, potentially creating a more supportive environment that enhances engagement and recovery. Overall, FS-CBT appears to be a promising treatment option for women dealing with AUD.14678
Who Is on the Research Team?
Elizabeth E Epstein, PHD
Principal Investigator
University of Massachusetts Chan Medical School
Are You a Good Fit for This Trial?
This trial is for U.S. Veteran women aged 18 or older with Alcohol Use Disorder (AUD) who have consumed alcohol within the last 90 days and are enrolled in healthcare at VA New York Harbor Healthcare System. They must speak and read English well. Pregnant women, prisoners, or those acutely suicidal or with severe mental illness symptoms are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Female-Specific Cognitive Behavioral Therapy (FS-CBT) or Usual Care for Alcohol Use Disorder
Follow-up
Participants are monitored for safety and effectiveness after treatment
Implementation Evaluation
Evaluation of implementation barriers and facilitators using qualitative interviews and quantitative data
What Are the Treatments Tested in This Trial?
Interventions
- Female-Specific Cognitive Behavioral Therapy (FS-CBT)
- Usual Care
Female-Specific Cognitive Behavioral Therapy (FS-CBT) is already approved in United States for the following indications:
- Alcohol Use Disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Massachusetts, Worcester
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator